Form 4: Ceribell CEO Exercises Options and Sells Shares Under Pre-Arranged Trading Plan

Ceribell, Inc.'s President and CEO, Xingjuan Chao, exercised stock options and subsequently sold 25,000 shares of common stock for approximately $17.00 per share, as part of a Rule 10b5-1 trading plan.

Summary

• Xingjuan Chao, Ceribell, Inc.'s President and CEO, exercised options to acquire 25,000 shares of common stock at an exercise price of $2.24 per share on June 3, 2025.
• Concurrently, Ms. Chao sold 25,000 shares of common stock at a weighted average price of $17.00 per share, with individual sales ranging from $16.81 to $17.20.
• Both the option exercise and the subsequent sale were conducted under a pre-arranged Rule 10b5-1 trading plan.
• Following these transactions, Ms. Chao directly holds 776,022 shares of common stock.
• Additionally, 369,088 shares are indirectly held by the ACP 2021 Trust, where Ms. Chao is a co-trustee.
• Ms. Chao retains 77,551 unexercised stock options with an exercise price of $2.24, which were granted on November 10, 2015, and are fully vested.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a CEO selling shares can sometimes be viewed negatively, the fact that it was done under a Rule 10b5-1 plan mitigates concerns about insider sentiment. Furthermore, the significant profit realized from the option exercise and sale highlights the stock's appreciation, which is positive for shareholders.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale rather than a reaction to new, negative information.
• The CEO realized a significant profit from exercising options at $2.24 and selling shares at an average of $17.00, demonstrating the value appreciation of the company's stock.

Negatives

• The sale of 25,000 shares by the President and CEO, even if pre-planned, reduces her direct ownership stake in the company.

Risks

• While executed under a 10b5-1 plan, insider selling, particularly by a CEO, can sometimes be perceived negatively by investors, potentially leading to questions about management's long-term confidence, though this is mitigated by the pre-planned nature.

Future Outlook

The document, a Form 4, reports an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
• The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
• The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends. It reflects a personal financial decision by a key executive rather than a company-wide strategic or operational update.

Comparison to Industry Standards

• This document reports an individual insider transaction and does not contain information suitable for comparison to global industry benchmarks, specific comparable companies, or project results. Such comparisons would typically be found in financial statements or operational reports.

Related Party Transactions

• Xingjuan Chao, as a co-trustee of the ACP 2021 Trust, is deemed to share beneficial ownership of 369,088 shares held by the trust, though she disclaims beneficial ownership except to the extent of her pecuniary interest.

Stakeholder Impact

• Shareholders: The sale by the CEO, even if pre-planned, might lead to questions about management's confidence, but the execution under a 10b5-1 plan generally reduces this concern. The significant profit realized by the CEO from the option exercise and sale could be seen as a positive indicator of stock performance.

Next Steps

• The document does not mention any specific future actions, events, or milestones for the company or the reporting person beyond the completion of the reported transactions.

Key Dates

Recommendation

Keywords

Ceribell Inc., CBLL, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Xingjuan Chao, CEO, Rule 10b5-1 Plan, Beneficial Ownership